- Home
- QVCGA vs PULM Comparison
QVCGA vs PULM Comparison
Compare QVCGA & PULM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QVCGA
- PULM
- Stock Information
- Founded
- QVCGA 1991
- PULM 2003
- Country
- QVCGA United States
- PULM United States
- Employees
- QVCGA N/A
- PULM N/A
- Industry
- QVCGA
- PULM Biotechnology: Pharmaceutical Preparations
- Sector
- QVCGA
- PULM Health Care
- Exchange
- QVCGA NYSE
- PULM Nasdaq
- Market Cap
- QVCGA 26.1M
- PULM 33.2M
- IPO Year
- QVCGA N/A
- PULM N/A
- Fundamental
- Price
- QVCGA $2.90
- PULM $6.56
- Analyst Decision
- QVCGA
- PULM
- Analyst Count
- QVCGA 0
- PULM 0
- Target Price
- QVCGA N/A
- PULM N/A
- AVG Volume (30 Days)
- QVCGA 144.1K
- PULM 60.4K
- Earning Date
- QVCGA 08-07-2025
- PULM 08-12-2025
- Dividend Yield
- QVCGA N/A
- PULM N/A
- EPS Growth
- QVCGA N/A
- PULM N/A
- EPS
- QVCGA N/A
- PULM N/A
- Revenue
- QVCGA $9,800,000,000.00
- PULM $1,921,000.00
- Revenue This Year
- QVCGA $2.89
- PULM N/A
- Revenue Next Year
- QVCGA $0.45
- PULM $134.88
- P/E Ratio
- QVCGA N/A
- PULM N/A
- Revenue Growth
- QVCGA N/A
- PULM N/A
- 52 Week Low
- QVCGA $2.27
- PULM $1.78
- 52 Week High
- QVCGA $39.74
- PULM $10.40
- Technical
- Relative Strength Index (RSI)
- QVCGA N/A
- PULM 40.87
- Support Level
- QVCGA N/A
- PULM $6.51
- Resistance Level
- QVCGA N/A
- PULM $6.96
- Average True Range (ATR)
- QVCGA 0.00
- PULM 0.89
- MACD
- QVCGA 0.00
- PULM -0.13
- Stochastic Oscillator
- QVCGA 0.00
- PULM 42.38
About QVCGA QVC GROUP INC
QVC Group Inc is a live social shopping company with six retail brands QVC, HSN, Ballard Designs, Frontgate, Garnet Hill, Grandin Road, and other minority interests. QVC offers assortment of ,quality merchandise and classifies its products into six groups: home, apparel, beauty, accessories, electronics and jewelry. The company has three reportable segments: QxH, QVC International, and CBI. Majority of revenue is from Home products, from QxH segment. Company also operates in Japan, Germany and Other foreign countries.
About PULM Pulmatrix Inc.
Pulmatrix Inc is a biopharmaceutical company that has focused on the development of novel inhaled therapeutic products intended to prevent and treat migraine and respiratory diseases with important unmet medical needs using its patented dry powder delivery technology, iSPERSE. Its pipeline of clinical assets includes PUR3100 for the treatment of acute migraine, PUR1800 for the treatment of acute exacerbations of chronic obstructive pulmonary disease (AECOPD), and PUR1900 for the treatment of ABPA in patients with asthma and in patients with cystic fibrosis (CF).